Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31540582 | 0.85 | ALDH1A1 (0.71) | ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6 | |
| SCHEMBL1823342 | 0.83 | GPR84 (0.46) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL9214539 | 0.82 | CYP2A6 (0.52) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL19864880 | 0.82 | HSP90AA1 (0.45) | ALDH1A1HSD17B10MAPK14CYP2A6HPGD | |
| SCHEMBL4181934 | 0.81 | ALDH1A1 (0.58) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL9068487 | 0.80 | CYP2A6 (0.56) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL29391827 | 0.80 | ALDH1A1 (0.65) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL30186719 | 0.80 | ALDH1A1 (0.65) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL268735 | 0.80 | ALDH1A1 (0.65) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 | |
| SCHEMBL19862344 | 0.79 | AKR1B1 (0.44) | ALDH1A1HSD17B10HIF1ACYP1B1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
| US-20180047907-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
| EP-0272621-B1 | Method for the production of 5H-dibenzo[a,d]cyclohepten-5-ones | BASF Aktiengesellschaft (DE) | 1991-11-27 | — | — | EP | disclosed |
| US-4845302-A | Preparation of 5H-dibenzo[a,d]cyclohepten-5-ones | BASF AKTIENGSELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
| EP-0272621-A2 | Method for the production of 5H-dibenzo[a,d]cyclohepten-5-ones | BASF Aktiengesellschaft (DE) | 1988-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | ORC3, AOX1, RCOR3 | ALDH1A1 976/4885HSD17B10 2992/4885HIF1A 4328/4885 |
| US-20180047907-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | CNKSR1, CBX4, RBX1 | ALDH1A1 1096/4885HSD17B10 3506/4885HIF1A 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.